XML 54 R19.htm IDEA: XBRL DOCUMENT
v3.22.1

Fair Value Measurements | 3 Months Ended
--- | ---
Mar. 31, 2022
Fair Value Disclosures [Abstract] |
Fair Value Measurements | Fair Value Measurements Fair value of an asset or liability is the price that would be received to sell that asset or paid to transfer that liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC Topic 820 establishes a fair value hierarchy for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows: Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the Company has the ability to access as of the measurement date. Level 2: Significant other observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, and other inputs that are observable or can be corroborated by observable market data. Level 3: Significant unobservable inputs that reflect a company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability. The Company bases fair value of assets and liabilities on quoted market prices, prices for similar assets or liabilities, quoted prices in markets that are not active, and other inputs that are observable or can be corroborated by observable market data. If such information is not available, fair value is based upon internally developed models that primarily use, as inputs, observable market-based parameters. Valuation adjustments may be made to ensure that financial instruments are recorded at fair value. These adjustments may include amounts to reflect counterparty creditworthiness, as well as unobservable parameters. Any such valuation adjustments are applied consistently over time. The Company’s valuation methodologies may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. While management believes the Company’s valuation methodologies are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. Furthermore, the reported fair value amounts have not been comprehensively revalued since the presentation dates, and therefore, estimates of fair value after the balance sheet date may differ significantly from the amounts presented herein. A more detailed description of the valuation methodologies used for assets and liabilities measured at fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy, is set forth below. Financial Assets and Liabilities The Company used the following methods and significant assumptions to estimate fair value for financial assets and liabilities measured on a recurring basis. Securities Available for Sale. Securities available for sale are reported at fair value utilizing Level 1, Level 2, and Level 3 inputs. The fair value of securities available for sale is determined by utilizing a market approach by obtaining quoted prices on nationally recognized securities exchanges (other than forced or distressed transactions) that occur in sufficient volume or matrix pricing, which is a mathematical technique used widely in the industry to value debt securities without relying exclusively on quoted prices for the specific securities, but rather by relying on the securities’ relationship to other benchmark quoted securities. If such measurements are unavailable, the security is classified as Level 3. Significant judgment is required to make this determination. The Company utilizes a third party pricing service provider to value its Level 1 and Level 2 investment securities. Annually, the Company obtains an independent auditor’s report from its third party pricing service provider regarding its controls over investment securities. On a quarterly basis, the Company reprices its debt securities with a third party that is independent of the primary pricing service provider to verify the reasonableness of the fair values. Derivatives. Derivatives are reported at fair value utilizing Level 2 inputs. The Company utilizes a market approach by obtaining dealer quotations to value its customer interest rate swaps. The Company’s derivatives are included within "other assets" and "other liabilities" in the accompanying consolidated balance sheets. Derivative assets are typically secured through securities with financial counterparties or cross collateralization with a borrowing customer. Derivative liabilities are typically secured through the Company pledging securities to financial counterparties or, in the case of a borrowing customer, by the right of setoff. The Company considers factors such as the likelihood of default by itself and its counterparties, right of setoff, and remaining maturities in determining the appropriate fair value adjustments. All derivative counterparties approved by the Company's Asset and Liability Committee ("ALCO") are regularly reviewed, and appropriate business action is taken to adjust the exposure to certain counterparties, if necessary. Counterparty exposure is evaluated by netting positions that are subject to master netting agreements, as well as considering the amount of marketable collateral securing the position. This approach used to estimate impacted exposures to counterparties is also used by the Company to estimate its own credit risk in derivative liability positions. To date, no material losses have been incurred due to a counterparty's inability to pay any undercollateralized position. There was no significant change in the value of derivative assets and liabilities attributed to credit risk that would have resulted in a derivative credit risk valuation adjustment at March 31, 2022. The Company may be required, from time to time, to measure certain financial assets and financial liabilities at fair value on a nonrecurring basis. Financial assets measured at fair value on a nonrecurring basis include individually evaluated loans reported at the fair value of the underlying collateral if repayment is expected solely from the collateral. Collateral values are estimated using Level 3 inputs based on observable market data for both real estate collateral and non-real estate collateral. The following table presents assets and liabilities measured at fair value (in thousands):
| Total | Level 1 | Level 2 | Level 3 | Total Gains (Losses)
March 31, 2022 |  |  |  |  |
Recurring fair value measurements |  |  |  |  |
Financial Assets |  |  |  |  |
Obligations of states and political subdivisions | $ | 255,007 |  | $ | — |  | $ | 255,007 |  | $ | — |  |
Mortgage-backed securities: |  |  |  |  |
U.S. Government agencies | 1,115,093 |  | — |  | 1,115,093 |  | — |  |
Private label | 8,463 |  | — |  | 5,268 |  | 3,195 |  |
Trust preferred securities | 4,300 |  | — |  | 4,300 |  | — |  |
Corporate securities | 26,650 |  | — |  | 26,650 |  | — |  |
Marketable equity securities | 8,489 |  | 4,074 |  | 4,415 |  | — |  |
Certificates of deposit held for investment | 996 |  | — |  | 996 |  | — |  |
Derivative assets | 38,822 |  | — |  | 38,822 |  | — |  |
Financial Liabilities |  |  |  |  |
Derivative liabilities | 27,238 |  | — |  | 27,238 |  | — |  |
Nonrecurring fair value measurements |  |  |  |  |
Non-Financial Assets |  |  |  |  |
Other real estate owned | 1,099 |  | — |  | — |  | 1,099 |  | (20) |
December 31, 2021 |  |  |  |  |
Recurring fair value measurements |  |  |  |  |
Financial Assets |  |  |  |  |
Obligations of states and political subdivisions | $ | 272,216 |  | $ | — |  | $ | 272,216 |  | $ | — |  |
Mortgage-backed securities: |  |  |  |  |
U.S. Government agencies | 1,094,311 |  | — |  | 1,094,311 |  | — |  |
Private label | 9,108 |  | — |  | 5,647 |  | 3,461 |  |
Trust preferred securities | 4,203 |  | — |  | 4,203 |  | — |  |
Corporate securities | 28,327 |  | — |  | 28,327 |  | — |  |
Marketable equity securities | 9,211 |  | 4,134 |  | 5,077 |  | — |  |
Certificates of deposit held for investment | 996 |  | — |  | 996 |  | — |  |
Derivative assets | 29,029 |  | — |  | 29,029 |  | — |  |
Financial Liabilities |  |  |  |  |
Derivative liabilities | 24,283 |  | — |  | 24,283 |  | — |  |
Nonrecurring fair value measurements |  |  |  |  |
Financial Assets |  |  |  |  |
Loans individually evaluated | $ | — |  | $ | — |  | $ | — |  | $ | — |  | $ | (478) |
Non-Financial Assets |  |  |  |  |
Other real estate owned | 1,319 |  | — |  | — |  | 1,319 |  | (2) |
The Company's financial assets and liabilities measured at fair value on a nonrecurring basis using significant unobservable inputs (Level 3) include impaired loans that were remeasured and reported at fair value through a specific valuation allowance allocation of the allowance for credit losses based upon the fair value of the underlying collateral (in thousands). The fair value of impaired loans is estimated using one of several methods, including collateral value, liquidation value and discounted cash flows. The significant unobservable inputs used in the fair value measurement of collateral for collateral-dependent impaired loans primarily relate to discounts applied to the customers’ reported amount of collateral. The amount of collateral discount depends upon the marketability of the underlying collateral. During the three months ended March 31, 2022 and 2021, collateral discounts ranged from 10% to 30%. During the three months ended March 31, 2022 and 2021, the Company had no Level 2 financial assets and liabilities that were measured on a nonrecurring basis. Non-Financial Assets and Liabilities The Company has no non-financial assets or liabilities measured at fair value on a recurring basis. Certain non-financial assets measured at fair value on a non-recurring basis include other real estate owned (“OREO”), which is measured at the lower of cost or fair value. Fair Value of Financial Instruments ASC Topic 825 “Financial Instruments,” as amended, requires disclosure of fair value information about financial instruments, whether or not recognized in the balance sheet, for which it is practicable to estimate that value. In cases where quoted market prices are not available, fair values are based on estimates using present value or other valuation techniques. Those techniques are significantly affected by the assumptions used, including discount rates and estimate of future cash flows. In that regard, the derived fair value estimates cannot be substantiated by comparison to independent markets and, in many cases, could not be realized in immediate settlement of the instrument. ASC Topic 825 excludes certain financial instruments and all nonfinancial instruments from its disclosure requirements. Accordingly, the aggregate fair value amounts presented do not represent the underlying value of the Company. The following table represents the estimates of fair value of financial instruments (in thousands). For short-term financial assets such as cash and cash equivalents, the carrying amount is a reasonable estimate of fair value due to the relatively short time between the origination of the instrument and its expected realization. For financial liabilities such as noninterest-bearing demand, interest-bearing demand and savings deposits, the carrying amount is a reasonable estimate of fair value due to these products having no stated maturity.
| Carrying Amount | Fair Value | Level 1 | Level 2 | Level 3
March 31, 2022 |  |  |  |  |
Assets:
Cash and cash equivalents | $ | 598,048 |  | $ | 598,048 |  | $ | 598,048 |  | $ | — |  | $ | — |
Securities available-for-sale | 1,409,513 |  | 1,409,513 |  | — |  | 1,406,318 |  | 3,195 |
Marketable equity securities | 8,489 |  | 8,489 |  | 4,074 |  | 4,415 |  | — |
Net loans | 3,542,625 |  | 3,461,145 |  | — |  | — |  | 3,461,145 |
Accrued interest receivable | 16,101 |  | 16,101 |  | 16,101 |  | — |  | — |
Derivative assets | 38,822 |  | 38,822 |  | — |  | 38,822 |  | — |
Liabilities: |  |  |  |  |
Deposits | 4,998,845 |  | 4,991,704 |  | 3,974,286 |  | 1,017,418 |  | — |
Short-term debt | 288,483 |  | 288,483 |  | — |  | 288,483 |  | — |
Accrued interest payable | 491 |  | 491 |  | 491 |  | — |  | — |
Derivative liabilities | 27,238 |  | 27,238 |  | — |  | 27,238 |  | — |
December 31, 2021 |  |  |  |  |
Assets: |  |  |  |  |
Cash and cash equivalents | $ | 634,631 |  | $ | 634,631 |  | $ | 634,631 |  | $ | — |  | $ | — |
Securities available-for-sale | 1,408,165 |  | 1,408,165 |  | — |  | 1,404,704 |  | 3,461 |
Marketable equity securities | 9,211 |  | 9,211 |  | 4,134 |  | 5,077 |  | — |
Net loans | 3,525,648 |  | 3,456,539 |  | — |  | — |  | 3,456,539 |
Accrued interest receivable | 15,627 |  | 15,627 |  | 15,627 |  | — |  | — |
Derivative assets | 29,029 |  | 29,029 |  | — |  | 29,029 |  | — |
Liabilities: |  |  |  |  |
Deposits | 4,925,336 |  | 4,926,724 |  | 3,856,421 |  | 1,070,303 |  | — |
Short-term debt | 312,458 |  | 312,458 |  | — |  | 312,458 |  | — |
Accrued interest payable | 600 |  | 600 |  | 600 |  | — |  | — |
Derivative liabilities | 24,283 |  | 24,283 |  | — |  | 24,283 |  | — |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration